Clinical Trial Update: Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating definitive chemoradiotherapy with cetuximab for locally advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasm

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Gabriella Alexandersson von Döbeln | Conditions: Esophageal Neoplasm | Phase 2 | Status: UNKNOWN